125 reports of this reaction
1.9% of all OMEPRAZOLE AND SODIUM BICARBONATE reports
#11 most reported adverse reaction
FATIGUE is the #11 most commonly reported adverse reaction for OMEPRAZOLE AND SODIUM BICARBONATE, manufactured by Santarus, Inc... There are 125 FDA adverse event reports linking OMEPRAZOLE AND SODIUM BICARBONATE to FATIGUE. This represents approximately 1.9% of all 6,647 adverse event reports for this drug.
Patients taking OMEPRAZOLE AND SODIUM BICARBONATE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for OMEPRAZOLE AND SODIUM BICARBONATE, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for OMEPRAZOLE AND SODIUM BICARBONATE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 125 FDA reports for OMEPRAZOLE AND SODIUM BICARBONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 1.9% of all adverse event reports for OMEPRAZOLE AND SODIUM BICARBONATE, making it a notable side effect.
If you experience fatigue while taking OMEPRAZOLE AND SODIUM BICARBONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.